The Comparative Impact of Globalization of Clinical Trials in India and China

Inhaltsverzeichnis (Table of Contents)

• Globalization of clinical trials
• Indian drug regulatory body versus the Chinese system

Zielsetzung und Themenschwerpunkte (Objectives and Key Themes)

This paper explores the impact of globalization on clinical trials, particularly in India and China. The author aims to analyze the benefits and challenges of conducting clinical trials in these emerging markets, comparing their regulatory frameworks and ethical considerations.

• Ethics in the conduct of clinical trials
• Good clinical practice (GCP) and global acceptance
• Intellectual property security
• The role of government in global clinical trials
• Economic realities of clinical trial outsourcing

Zusammenfassung der Kapitel (Chapter Summaries)

• Globalization of clinical trials: This chapter introduces the concept of globalization in clinical trials and explains the driving forces behind its growth, including the need for cost-efficient drug research and development. It also discusses the opportunities and challenges associated with conducting clinical trials in emerging markets like India and China.
• Indian drug regulatory body versus the Chinese system: This chapter focuses on the specific regulatory frameworks and challenges faced by pharmaceutical companies in India and China. It highlights the strengths and weaknesses of each country's system and how they are adapting to the influx of global clinical trials.

Schlüsselwörter (Keywords)

The main keywords and focus topics of this paper include globalization, clinical trials, India, China, regulatory frameworks, ethics, good clinical practice (GCP), intellectual property security, economic realities, and emerging markets.